Similar articles for PMID: 21207250

Year	Number of Results
1994	1
1998	1
1999	1
2000	5
2001	3
2002	5
2003	2
2004	5
2005	2
2006	4
2007	7
2008	8
2009	4
2010	9
2011	6
2012	5
2013	9
2014	9
2015	6
2016	3
2017	6
2018	4
2019	2
2020	1
2021	3
2022	3
2023	1
2024	0

1

Simvastatin therapy reduces prooxidant-antioxidant balance: results of a placebo-controlled cross-over trial.

Parizadeh SM, Azarpazhooh MR, Moohebati M, Nematy M, Ghayour-Mobarhan M, Tavallaie S, Rahsepar AA, Amini M, Sahebkar A, Mohammadi M, Ferns GA. Parizadeh SM, et al. Lipids. 2011 Apr;46(4):333-40. doi: 10.1007/s11745-010-3517-x. Epub 2011 Jan 5. Lipids. 2011. PMID: 21207250 Clinical Trial.

2

Prooxidant-antioxidant balance in pregnancy: a randomized double-blind placebo-controlled trial of selenium supplementation.

Tara F, Rayman MP, Boskabadi H, Ghayour-Mobarhan M, Sahebkar A, Alamdari DH, Razavi BS, Tavallaie S, Azimi-Nezhad M, Shakeri MT, Oladi M, Yazarlu O, Ouladan S, Sangani MT, Omran FR, Ferns G. Tara F, et al. J Perinat Med. 2010 Sep;38(5):473-8. doi: 10.1515/jpm.2010.068. J Perinat Med. 2010. PMID: 20629489 Clinical Trial.

3

Effects of statin therapy on serum trace element status in dyslipidemic patients: results of a randomized placebo-controlled cross-over trial.

Farrokhi F, Moohebati M, Aghdaei HR, Ghaffarzadegan K, Norouzi F, Sahebkar A, Tavallaie S, Azarpazhooh MR, Ghayour-Mobarhan M, Ferns GA. Farrokhi F, et al. Clin Lab. 2012;58(9-10):1005-15. Clin Lab. 2012. PMID: 23163117 Clinical Trial.

4

Depression and anxiety symptoms are associated with prooxidant-antioxidant balance: A population-based study.

Shafiee M, Ahmadnezhad M, Tayefi M, Arekhi S, Vatanparast H, Esmaeili H, Moohebati M, Ferns GA, Mokhber N, Arefhosseini SR, Ghayour-Mobarhan M. Shafiee M, et al. J Affect Disord. 2018 Oct 1;238:491-498. doi: 10.1016/j.jad.2018.05.079. Epub 2018 Jun 13. J Affect Disord. 2018. PMID: 29935471

5

Simvastatin and oxidative stress in humans: A randomized, double-blinded, placebo-controlled clinical trial.

Rasmussen ST, Andersen JT, Nielsen TK, Cejvanovic V, Petersen KM, Henriksen T, Weimann A, Lykkesfeldt J, Poulsen HE. Rasmussen ST, et al. Redox Biol. 2016 Oct;9:32-38. doi: 10.1016/j.redox.2016.05.007. Epub 2016 May 30. Redox Biol. 2016. PMID: 27281490 Free PMC article. Clinical Trial.

6

Simvastatin treatment reduces heat shock protein 60, 65, and 70 antibody titers in dyslipidemic patients: A randomized, double-blind, placebo-controlled, cross-over trial.

Moohebati M, Bidmeshgi S, Azarpazhooh MR, Daloee MH, Ghayour-Mobarhan M, Tavallaie S, Amini M, Momenzadeh A, Sahebkar A, Paydar R, Rahsepar AA, Parizadeh SM, Akhlaghi S, Ferns GA. Moohebati M, et al. Clin Biochem. 2011 Feb;44(2-3):192-7. doi: 10.1016/j.clinbiochem.2010.09.016. Epub 2010 Sep 26. Clin Biochem. 2011. PMID: 20875810 Clinical Trial.

7

MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial.

Collins R, Armitage J, Parish S, Sleigh P, Peto R; Heart Protection Study Collaborative Group. Collins R, et al. Lancet. 2003 Jun 14;361(9374):2005-16. doi: 10.1016/s0140-6736(03)13636-7. Lancet. 2003. PMID: 12814710 Clinical Trial.

8

Simvastatin treatment prevents oxidative damage to DNA in whole blood leukocytes of dyslipidemic type 2 diabetic patients.

Manfredini V, Biancini GB, Vanzin CS, Dal Vesco AM, Cipriani F, Biasi L, Treméa R, Deon M, Peralba Mdo C, Wajner M, Vargas CR. Manfredini V, et al. Cell Biochem Funct. 2010 Jul;28(5):360-6. doi: 10.1002/cbf.1654. Cell Biochem Funct. 2010. PMID: 20589733 Clinical Trial.

9

Prognostic Factors Associating with Pro-oxidant-antioxidant Balance; Neutrophils to Lymphocytes Ratio, Vitamin D, Heat Shock Protein 27, and Red Cell Distribution Width.

Ghazizadeh H, Mirinezhad MR, Seyedi SMR, Sadabadi F, Ahmadnezhad M, Jaberi N, Pasdar A, Ferns GA, Esmaily H, Ghayour-Mobarhan M. Ghazizadeh H, et al. Arch Med Res. 2020 Apr;51(3):261-267. doi: 10.1016/j.arcmed.2020.02.006. Epub 2020 Feb 26. Arch Med Res. 2020. PMID: 32111498

10

Prooxidant-antioxidant balance as a new risk factor in patients with angiographically defined coronary artery disease.

Alamdari DH, Ghayour-Mobarhan M, Tavallaie S, Parizadeh MR, Moohebati M, Ghafoori F, Kazemi-Bajestani SM, Paletas K, Pegiou T, Koliakos G. Alamdari DH, et al. Clin Biochem. 2008 Apr;41(6):375-80. doi: 10.1016/j.clinbiochem.2007.12.008. Epub 2007 Dec 27. Clin Biochem. 2008. PMID: 18191639

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

101 results

Results by year